Viewing Study NCT00003251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-01-02 @ 8:15 AM
Study NCT ID: NCT00003251
Status: UNKNOWN
Last Update Posted: 2013-12-04
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
Sponsor: University of Illinois at Chicago
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Drug/Agent Toxicity by Tissue/Organ View
None Head and Neck Cancer View
None Radiation Toxicity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III nasopharyngeal cancer View
None stage IV nasopharyngeal cancer View
None recurrent nasopharyngeal cancer View
None stage III salivary gland cancer View
None stage IV salivary gland cancer View
None recurrent salivary gland cancer View
None salivary gland squamous cell carcinoma View
None high-grade salivary gland mucoepidermoid carcinoma View
None stage III lip and oral cavity cancer View
None stage IV lip and oral cavity cancer View
None recurrent lip and oral cavity cancer View
None stage III hypopharyngeal cancer View
None stage IV hypopharyngeal cancer View
None recurrent hypopharyngeal cancer View
None stage III laryngeal cancer View
None stage IV laryngeal cancer View
None recurrent laryngeal cancer View
None stage III paranasal sinus and nasal cavity cancer View
None stage IV paranasal sinus and nasal cavity cancer View
None recurrent paranasal sinus and nasal cavity cancer View
None stage III oropharyngeal cancer View
None stage IV oropharyngeal cancer View
None recurrent oropharyngeal cancer View
None stage III squamous cell carcinoma of the lip and oral … View
None stage III mucoepidermoid carcinoma of the oral cavity View
None stage IV squamous cell carcinoma of the lip and oral … View
None stage IV mucoepidermoid carcinoma of the oral cavity View
None recurrent squamous cell carcinoma of the lip and oral cavity View
None recurrent mucoepidermoid carcinoma of the oral cavity View
None stage III squamous cell carcinoma of the oropharynx View
None stage IV squamous cell carcinoma of the oropharynx View
None recurrent squamous cell carcinoma of the oropharynx View
None stage III squamous cell carcinoma of the nasopharynx View
None stage IV squamous cell carcinoma of the nasopharynx View
None recurrent squamous cell carcinoma of the nasopharynx View
None stage III squamous cell carcinoma of the hypopharynx View
None stage IV squamous cell carcinoma of the hypopharynx View
None recurrent squamous cell carcinoma of the hypopharynx View
None stage III squamous cell carcinoma of the larynx View
None stage IV squamous cell carcinoma of the larynx View
None recurrent squamous cell carcinoma of the larynx View
None stage III squamous cell carcinoma of the paranasal sinus and … View
None stage IV squamous cell carcinoma of the paranasal sinus and … View
None recurrent squamous cell carcinoma of the paranasal sinus and nasal … View
None drug/agent toxicity by tissue/organ View
None radiation toxicity View